Appropriateness rating for the application of optimal medical therapy and multidisciplinary care among heart failure patients.

ESC Heart Failure
Satoshi ShojiMitsuaki Isobe

Abstract

Clinical guidelines for improving the patients' quality of care vary in clinical practice, particularly in super-aging societies, like in Japan. We aimed to develop a set of appropriate-use criteria (AUC) for contemporary heart failure (HF) management to assist physicians in decision making. With the use of the RAND methodology, a multidisciplinary writing group developed patient-based clinical scenarios in 10 selected key topics, stratified mainly by HF stage, age, and renal function. Nine nationally recognized expert panellists independently rated the clinical scenario appropriateness twice on a scale of 1-9, as 'appropriate' (7-9), 'may be appropriate' (4-6), or 'rarely appropriate' (1-3). Decisions were based on clinical evidence and professional opinions in the context of available resource use and costs. An interactive round-table discussion was held between the first and second ratings; the median score of the nine experts was then assigned to an appropriate-use category. Most clinical scenarios without strong evidence were evaluated as 'may be appropriate'. Frailty assessments in elderly patients (age ≥ 75 years), regardless of the HF stage, and advanced care planning in patients with stage C/D HF, regardless of age, we...Continue Reading

References

Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Jun 2, 2001·The New England Journal of Medicine·M PackerUNKNOWN Carvedilol Prospective Randomized Cumulative Survival Study Group
Oct 18, 2005·Journal of the American College of Cardiology·Manesh R PatelUNKNOWN American College of Cardiology Foundation
Jan 4, 2007·JAMA : the Journal of the American Medical Association·Gregg C FonarowUNKNOWN OPTIMIZE-HF Investigators and Hospitals
Oct 22, 2009·JAMA : the Journal of the American Medical Association·Nancy M AlbertGregg C Fonarow
Nov 16, 2010·The New England Journal of Medicine·Faiez ZannadUNKNOWN EMPHASIS-HF Study Group
May 19, 2012·Journal of the American College of Cardiology·Edward L HannanSpencer B King
Aug 21, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·Yasuhiko Sakata, Hiroaki Shimokawa
Sep 2, 2014·The New England Journal of Medicine·John J V McMurrayUNKNOWN PARADIGM-HF Investigators and Committees
Sep 7, 2014·Lancet·Dipak KotechaUNKNOWN Beta-Blockers in Heart Failure Collaborative Group
Dec 3, 2014·American Heart Journal·Taku InoharaKeiichi Fukuda
Jun 19, 2015·The American Journal of the Medical Sciences·Sahil AgrawalMark Segal
Jul 5, 2015·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Ramin ShadmanWayne C Levy
Apr 14, 2016·Circulation·Michael W RichUNKNOWN American Heart Association Older Populations Committee of the Council on Clinical Cardiology, Council on Cardiovascular and
Jul 13, 2016·International Journal of Cardiology·Quan L HuynhThomas H Marwick
Apr 24, 2017·Journal of Cardiac Failure·Jane A CannonTerence J Quinn
May 4, 2017·Journal of the American College of Cardiology·Dipak KotechaUNKNOWN Beta-Blockers in Heart Failure Collaborative Group
Jul 6, 2017·The New England Journal of Medicine·Li ShenJohn J V McMurray
Oct 19, 2017·European Heart Journal·John G F ClelandUNKNOWN Beta-blockers in Heart Failure Collaborative Group
Jun 7, 2018·European Journal of Heart Failure·Lauren B Cooper, Adrian F Hernandez
Sep 13, 2019·Circulation Journal : Official Journal of the Japanese Circulation Society·Hiroyuki TsutsuiUNKNOWN Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group
Sep 20, 2019·The New England Journal of Medicine·John J V McMurrayUNKNOWN DAPA-HF Trial Committees and Investigators
Jun 25, 2020·Annals of Palliative Medicine·Yuri Tokunaga-NakawataseSetsuko Watabe

❮ Previous
Next ❯

Software Mentioned

Google Form

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.